Clinical Trial

Dynamic Monitoring of ctDNA and HPV DNA in Plasma for the Early Prediction of Recurrence After Cervical Cancer Surgery

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 20, 2024 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
Assess the sensitivity, specificity, positive predictive value, and negative predictive value of dynamic monitoring of circulating tumor DNA (ctDNA) combined with circulating HPV DNA (cfHPV DNA) for early prediction of recurrence in cervical cancer post-surgery or post-treatment, and compare its advantages and disadvantages with existing diagnostic methods.
Trial Details
NCT Number NCT06420427
Lead Sponsor The Third Affiliated Hospital of Guangzhou Medical University
Conditions cfHPV DNA in Plasma of Cervical Cancer Patients
Enrollment 150 participants
Start Date 2024-01-01
Primary Completion 2025-12-31 (estimated)
Study Completion 2027-01-30 (estimated)
Updated on ClinicalTrials.gov 2024-05-20